FOXO1 and lymphoma: In MCL, FoxO1 serves as a master factor driving MCL‐lineage‐specific transcription programs that ensure the survival and proliferation of lymphoma cells (Fig. 5) [9], and a novel FoxO1 inhibitor has been tested in this context (cpd10) [123].